Influence of Ribavirin on the Initial Virological Response in Treatment Naïve Patients With Hepatitis C Genotype 1 Infection

Clinical trial NCT02716779 · COMPLETED

Trial details

NCT number: NCT02716779
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatitis C, Chronic

Start date: 2007-04-01
Primary completion: 2010-04-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.